Membrane Interaction of Disease-Related Dynorphin A Variants
- 10 June 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 52 (24) , 4157-4167
Abstract
The membrane interaction properties of two single-residue variants, R6W and L5S, of the 17-amino acid neuropeptide dynorphin A (DynA) were studied by circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy. Corresponding gene mutations have recently been discovered in humans and causatively linked to a neurodegenerative disorder. The peptides were investigated in buffer and in isotropic solutions of q = 0.3 bicelles with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) or DMPC (0.8) and 1,2-dimyristoyl-sn-glycero-3-phospho(1′-rac-glycerol) (DMPG) (0.2). The CD results and the NMR secondary chemical shifts show that R6W-DynA has a small α-helical fraction in buffer, which increases in the presence of bicelles, while L5S-DynA is mainly unstructured under all conditions studied here. R6W-DynA has an almost complete association with zwitterionic bicelles (∼90%, as probed by NMR diffusion experiments), similar to the behavior of wtDynA, while L5S-DynA has a weaker association (∼50%). For all peptides, the level of bicelle association is increased in negatively charged bicelles. The L5A-DynA peptide adopts a very shallow position in the headgroup region of the bicelle bilayer, as studied by paramagnetic spin relaxation enhancement experiments using paramagnetic probes. Similarly, the results show that R6W-DynA is more deeply buried in the bilayer, with only the C-terminal residues exposed to solvent, again more similar to the case of wild-type DynA. We suggest that the results presented here may explain the differences in cell toxicity of these disease-related neuropeptide variants.Keywords
This publication has 72 references indexed in Scilit:
- Structure of the human κ-opioid receptor in complex with JDTicNature, 2012
- Prodynorphin Mutations Cause the Neurodegenerative Disorder Spinocerebellar Ataxia Type 23The American Journal of Human Genetics, 2010
- The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviorsBrain Research, 2010
- kappa-Opioid receptor signaling and brain reward functionBrain Research Reviews, 2009
- The Effects of C-Terminal Modifications on the Opioid Activity of [N-BenzylTyr1]Dynorphin A-(1−11) AnaloguesJournal of Medicinal Chemistry, 2009
- Design, Synthesis, and Pharmacological Activities of Dynorphin A Analogues Cyclized by Ring-Closing MetathesisJournal of Medicinal Chemistry, 2009
- Sensitivity of secondary structure propensities to sequence differences between α‐ and γ‐synuclein: Implications for fibrillationProtein Science, 2006
- A Novel N-Terminal Cyclic Dynorphin A AnaloguecycloN,5[Trp3,Trp4,Glu5] Dynorphin A-(1−11)NH2That Lacks the Basic N-TerminusJournal of Medicinal Chemistry, 2003
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995
- IsolationLife Sciences, 1975